Elevated ALT and GGT predict all-cause mortality and hepatocellular carcinoma in Taiwanese male: a case-cohort study

[1]  S. Bolen,et al.  Body Mass Index and Colon Cancer Screening: A Systematic Review and Meta-Analysis , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[2]  I. Kamel,et al.  Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study , 2011, BMJ : British Medical Journal.

[3]  L. Holmberg,et al.  Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons - the Swedish AMORIS study. , 2011, European journal of cancer.

[4]  F. Sanai,et al.  A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[5]  Q. Anstee,et al.  Genetics of alcoholic and nonalcoholic fatty liver disease. , 2011, Seminars in liver disease.

[6]  K. Yun,et al.  Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans. , 2009, Atherosclerosis.

[7]  Jin-Lin Hou,et al.  Hepatocellular carcinoma in the Asia pacific region , 2009, Journal of gastroenterology and hepatology.

[8]  J. Everhart,et al.  Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. , 2009, Gastroenterology.

[9]  S. Bolen,et al.  The Association of Obesity and Cervical Cancer Screening: A Systematic Review and Meta‐analysis , 2009, Obesity.

[10]  M. Inoue,et al.  Serum aminotransferase level and the risk of hepatocellular carcinoma: a population-based cohort study in Japan , 2009, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[11]  W. Kim.  Clinical implications of short-term variability in liver function test results. , 2008, Gastroenterology.

[12]  M. Lazo,et al.  Brief Communication: Clinical Implications of Short-Term Variability in Liver Function Test Results , 2008, Annals of Internal Medicine.

[13]  M. Zwahlen,et al.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.

[14]  H. Ueshima,et al.  γ-Glutamyltransferase predicts cardiovascular death among Japanese women , 2007 .

[15]  S. Larsson,et al.  Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies , 2007, British Journal of Cancer.

[16]  O. Wagner,et al.  Gamma glutamyltransferase and long-term survival: is it just the liver? , 2007, Clinical chemistry.

[17]  Diederick E Grobbee,et al.  Analysis of case-cohort data: a comparison of different methods. , 2007, Journal of clinical epidemiology.

[18]  E. Bugianesi,et al.  Non-alcoholic steatohepatitis and cancer. , 2007, Clinics in liver disease.

[19]  R. D'Agostino,et al.  Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk: The Framingham Heart Study , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[20]  H. Ueshima,et al.  gamma-Glutamyltransferase predicts cardiovascular death among Japanese women. , 2007, Atherosclerosis.

[21]  Chien-Jen Chen,et al.  Secular trends and geographic variations of hepatitis B virus and hepatitis C virus‐associated hepatocellular carcinoma in Taiwan , 2006, International journal of cancer.

[22]  Chien-Jen Chen,et al.  Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched. , 2006, Epidemiologic reviews.

[23]  D. Lawlor,et al.  Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study , 2006, BMJ : British Medical Journal.

[24]  Jeanne M Clark,et al.  The Epidemiology of Nonalcoholic Fatty Liver Disease in Adults , 2006, Journal of clinical gastroenterology.

[25]  H. El‐Serag,et al.  The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[26]  H. Ueshima,et al.  The Value of Combining Serum Alanine Aminotransferase Levels and Body Mass Index to Predict Mortality and Medical Costs: a 10-year Follow-up Study of National Health Insurance in Shiga, Japan , 2005, Journal of epidemiology.

[27]  Long‐Teng Lee,et al.  Bright liver and alanine aminotransferase are associated with metabolic syndrome in adults. , 2005, Obesity research.

[28]  C. Tseng.  Mortality and causes of death in a national sample of diabetic patients in Taiwan. , 2004, Diabetes care.

[29]  I. Suh,et al.  Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study , 2004, BMJ : British Medical Journal.

[30]  Jeanne M Clark,et al.  Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. , 2003, JAMA.

[31]  F. Brancati,et al.  The prevalence and etiology of elevated aminotransferase levels in the United States , 2003, American Journal of Gastroenterology.

[32]  Chien-Jen Chen,et al.  Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan. , 2003, American journal of epidemiology.

[33]  Sang-hun Park.  Expanding the Natural History of Nonalcoholic Steatohepatitis: from Cryptogenic Cirrhosis to Hepatocellular Carcinoma , 2003 .

[34]  W. Shau,et al.  Four anthropometric indices and cardiovascular risk factors in Taiwan , 2002, International Journal of Obesity.

[35]  A. Zanella,et al.  Updated Definitions of Healthy Ranges for Serum Alanine Aminotransferase Levels , 2002, Annals of Internal Medicine.

[36]  S. Duffy,et al.  Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan , 2002, International journal of cancer.

[37]  I. McCutcheon,et al.  The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. , 2000, Endocrine reviews.

[38]  W E Barlow,et al.  Analysis of case-cohort designs. , 1999, Journal of clinical epidemiology.

[39]  D. Le Roith,et al.  Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. , 1997 .

[40]  D. Le Roith.  Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. , 1997, The New England journal of medicine.

[41]  E. Gunter,et al.  Laboratory procedures used for the third National Health and Nutrition Examination Survey (NHANES III), 1988-1994 , 1996 .

[42]  R. Esteban,et al.  Epidemiology of hepatitis C virus infection. , 1993, Journal of hepatology.

[43]  P. Loy.  International Classification of Diseases--9th revision. , 1978, Medical record and health care information journal.